1430817-33-6

Basic information

• Product Name: C₅₂H₇₀N₄O₈
• CAS NO: 1430817-33-6
• Molecular Weight: 879.15
• Mol File: 1430817-33-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₅₂H₇₀N₄O₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₅₂H₇₀N₄O₈(1430817-33-6)
• EPA Substance Registry System: C₅₂H₇₀N₄O₈(1430817-33-6)

Safety Data

• Hazardous Substances Data: 1430817-33-6(Hazardous Substances Data)

Upstream product

• 124-09-4 1,6-Hexanediamine 
• 1263815-54-8 C₂₃H₂₇NO₅ 
• 1263815-51-5 C₂₄H₂₉NO₆ 
• 1173933-72-6 C₂₀H₂₁NO₅ 
• 1173933-71-5 C₁₈H₁₇NO₅ 
• 7101-51-1 L-DOPA methyl ester 
• 1173933-70-4 C₁₇H₁₇NO₄ 
• 59-92-7 levodopa 

Downstream Products

• 1430817-34-7 C₄₂H₅₄N₄O₄ 

Relevant articles and documents

Synthesis and cytotoxicity of dinuclear platinum(II) complexes of (1S, 3S)-1,2,3,4-tetrahydroisoquinolines

A series of novel dinuclear platinum(II) complexes with (1S, 3S)-1,2,3,4-tetrahydroisoquinolines as the ligands were synthesized as potential anticancer agents in several steps starting from commercially available l-DOPA. The cytotoxicities of the series of dinuclear platinum(II) complexes of tetrahydroisoquinoline were tested against HCT-8, BEL-7402, A2780, MCF-7, Hela, A549 and BGC-823 cell lines by the MTT test. These complexes showed selective inhibition activity against cisplatin-insensitive cell line Skov3.